Last $115.15 USD
Change Today +1.40 / 1.23%
Volume 519.0K
VRTX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kenneth L. Horton

Chief Legal Officer and Executive Vice President, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 3 different industries.

See Board Relationships
47$4,539,551
As of Fiscal Year 2013

Background*

Mr. Kenneth L. Horton, also known as Ken, has been the Chief Legal Officer and an Executive Vice President at Vertex Pharmaceuticals Incorporated since June 2012. Mr. Horton holds responsibility for Vertex’s global legal and compliance functions. Mr. Horton served as General Counsel and an Executive Vice President of Corporate Development at MDI, Inc. (Nordion Inc). (Alternative Name is MDS Inc.) from December 2005 to April 4, 2011. He has more than 20 years of broad ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

2007-Present
Director

Education*

BA
Dartmouth College
JD
Harvard Law School

Other Affiliations*

Annual Compensation*

Salary$465,000
Total Annual Compensation$465,000

Stock Options*

Restricted Stock Awards$544,988
All Other Compensation$12,625
Exercisable Options46,117
Exercisable Options Value$994,686
Unexercisable Options150,508
Unexercisable Options Value$2,980,497
Total Value of Options$3,975,183
Total Number of Options196,625

Total Compensation*

Total Annual Cash Compensation$917,050
Total Short Term Compensation$465,000
Other Long Term Compensation$557,613
Total Calculated Compensation$4,539,551
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $115.15 USD +1.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.